*0011879108
*00520230608124904.0
*007ta
*008221109s2022    no a   e m    00  0 eng
*00901957nam a2200397 c 4500
*019  $bl
*020  $a9788230845516$qheftet
*035  $a(EXLNZ-47BIBSYS_NETWORK)999921907658902201
*035  $a(NO-DIMO)525deb6e-30e2-4ef9-a496-4975f0c9f347
*035  $a(NO-LaBS)17873678(bibid)
*035  $aoai:nb.no:pliktmonografi_000011681
*035  $aoai:nb.no:pliktmonografi_000011681
*040  $aNO-OsNB$bnob$erda
*0410 $aeng$bnob
*060 4$aQZ 380
*1001 $aSarnow, Katharina$d1984-$0(NO-TrBIB)1669188157958$4aut$_186417100
*24000$aInvestigating two important parameters involved in glioblastoma progression$_204863900
*24510$aInvestigating two important parameters involved in glioblastoma progression :$binvasion and treatment resistance$cKatharina Sarnow
*2463 $aInvestigating 2 important parameters involved in glioblastoma progression
*264 1$a[Bergen], Norway$bUniversity of Bergen$c2022
*300  $a1 bind (varierende paginering)$billustrasjoner
*336  $atekst$0http://rdaregistry.info/termList/RDAContentType/1020$2rdaco
*337  $auformidlet$0http://rdaregistry.info/termList/RDAMediaType/1007$2rdamt
*338  $abind$0http://rdaregistry.info/termList/RDACarrierType/1049$2rdact
*500  $aDelvis opptrykk av artikler
*502  $aAvhandling (ph.d.) - Universitetet i Bergen, 2022
*546  $aSammendrag på norsk
*650 2$aBrain$xcytology$0(DNLM)D001921Q000166$_184705900
*650 2$aGlioblastoma$0(DNLM)D005909$_13272500
*650 2$aOrganoids$xcytology$0(DNLM)D009940Q000166$_198253000
*655 7$aDoktoravhandlinger$0(uri)https://id.nb.no/vocabulary/ntsf/61$2ntsf$_202811400
*7001 $aSarnow, Katharina$d1984-$0(NO-TrBIB)1669188157958$tInvestigating two important parameters involved in glioblastoma progression$_186417100
*7102 $aUniversitetet i Bergen$bInstitutt for biomedisin$0(NO-TrBIB)10073621$4dgg$4pbl$_12926500
*85641$3Fulltekst$uhttps://www.nb.no/search?q=oaiid:"oai:nb.bibsys.no:999920333800502202"$yNettbiblioteket$zSøke-URL
*913  $aNorbok$bNB
*917  $ad
*999  $aoai:nb.bibsys.no:999920333800502202$b2022-11-09T03:07:48Z$z999920333800502202
^